Please check your internet connection and try again.
# Hyoscine butylbromide (Buscopan)
## Overview
Hyoscine butylbromide is an antimuscarinic agent that acts primarily on the smooth muscle of the gastrointestinal tract, reducing spasms and pain. It has minimal systemic absorption when given orally.
## Primary Indications
* Treatment of abdominal cramps and spasms.
* Symptomatic relief of irritable bowel syndrome (IBS).
## Adult Dosing
* **Oral:** 10 mg to 20 mg three times daily. Maximum daily dose typically not specified but should not exceed symptomatic relief needs.
* **Parenteral (IM/IV):** 20 mg every 4 to 6 hours as needed. Maximum daily dose not strictly defined, but typically limited by clinical need and parenteral administration guidelines.
## Pediatric Dosing
* **Oral:**
* **1 to 12 years:** 10 mg two to three times daily.
* Dosing for children under 1 year is generally not recommended due to potential for adverse effects and lack of established safety data.
* **Parenteral (IM/IV):** Not typically recommended for routine use in pediatric patients due to lack of established safety and efficacy data. Use with extreme caution and under strict medical supervision if deemed necessary.
## Dose Adjustments
No dose adjustments are typically required for renal or hepatic impairment due to minimal systemic absorption. However, caution is advised in elderly patients who may be more susceptible to anticholinergic side effects.
## Contraindications
* Hypersensitivity to hyoscine butylbromide or any component of the formulation.
* Certain conditions where the pupil dilates or heart rate increases could be harmful, such as narrow-angle glaucoma, prostatic hypertrophy, tachycardia, paralytic ileus, obstructive diseases of the gastrointestinal tract, or megacolon.
* Myasthenia gravis.
* Diagnosis of ileus or suspected gastrointestinal obstruction.
## Adverse Effects
Common adverse effects include dry mouth, blurred vision, constipation, urinary retention, and tachycardia. Less common effects include dizziness, headache, nausea, and skin reactions. Severe reactions are rare.
## Key Drug Interactions
* **Other Anticholinergics:** Additive anticholinergic effects (e.g., increased risk of constipation, urinary retention, dry mouth), including tricyclic antidepressants, antihistamines, and antipsychotics.
* **Dopamine antagonists (e.g., metoclopramide):** May reduce the effect of both drugs; co-administration should be approached with caution.
* **Prokinetic agents:** May antagonize the effects of prokinetic agents.
## Monitoring
* Monitor for relief of abdominal pain and spasms.
* Observe for signs of anticholinergic side effects (dry mouth, blurred vision, urinary hesitancy, constipation, tachycardia).
* If parenteral administration is used, monitor vital signs and signs of adverse reactions.
## Clinical Pearls
* Oral hyoscine butylbromide has low systemic bioavailability, making systemic anticholinergic effects less common at standard oral doses.
* Parenteral administration leads to higher systemic exposure and carries a greater risk of systemic anticholinergic effects.
* Effectiveness in conditions like IBS varies, and it may not be effective for all patients.
*Please verify the current prescribing information for definitive guidance, as local protocols and product-specific details may vary.*
